Maple Grove, MN – June 30, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Propafenone Hydrochloride Extended-Release Capsules in 225 mg, 325 mg and 425 mg strengths. Upsher-Smith’s product is AB-rated to ... Read More
Maple Grove, MN – June 23, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Ethacrynic Acid Tablets, USP in 25 mg strength. Ethacrynic Acid Tablets are a generic version of the brand ... Read More
Eligible Patients Pay $0 per Prescription* for Upsher-Smith Migraine Medications
Maple Grove, MN – June 23, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its continued commitment to people who suffer from migraines during National Migraine ... Read More
Osaka, Japan – June 18, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today announced the launch of 14 generic drugs with 29 strengths. They will be launched sequentially ... Read More
Osaka, Japan – June 3, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approval by the Ministry of Health, Labour and Welfare (MHLW) for Vardenafil tablets (the branded ... Read More
Osaka, Japan – March 23, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) decided, at the Board of Directors’ meeting held today, to implement changes in Representative Director. The ... Read More
